Ametek (AME) Q1 2026 (USD): EPS 1.74 (exp. 1.90), Revenue 1.93bln (exp. 1.91bln)

Ametek's Q1 2026 results showed an earnings per share (EPS) miss against expectations, coming in at 1.74 compared to the anticipated 1.90, while revenue slightly surpassed estimates.

Newsquawk StaffPublished On the live feed at 14 more headlines followed before this page went public
Newsquawk headlinesUTC

BOE STATEMENT: BoE maintains Bank Rate at 3.75%, as expected, in 8-1 vote (exp. 9-0); Pill votes to raise Bank Rate by 25bps to 4%

Bristol-Myers Squibb Company (BMY) Q1 2026 (USD): EPS 1.58 (exp. 1.42), revenue 11.5bln (exp. 10.9bln). Reaffirms 2026 guidance with total revenue & adj. EPS trending toward upper end of ranges

Ametek (AME) Q1 2026 (USD): EPS 1.74 (exp. 1.90), Revenue 1.93bln (exp. 1.91bln)

PREVIEW: BoE Policy Announcement & MPR due at 12:00BST/07:00EDT on Thursday, 30th April 2026

Eli Lilly and Company (LLY) Q1 2026 (USD): Adj. EPS 8.55 (exp. 6.88), Revenue 19.8bln (exp. 17.68bln), Mounjaro 8.66bln, Zepbound 4.16bln

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This miss on EPS, despite a revenue beat, may raise concerns about margins or cost pressures, impacting sentiment around the stock and potentially influencing analyst upgrades or downgrades moving forward.

Related headlines

The whole workspace, free to try.

Try it free